Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Schmerzmedizin
Erschienen in: Schmerzmedizin 1/2017

30.01.2017 | Komplexes regionales Schmerzsyndrom | Fortbildung

Supplementation

Vitamin C beim chronischen nicht spezifischen Kreuzschmerz

verfasst von: Olaf Buchbinder, Dr. Geert-Jan van Geffen, Prof. Dr. Gert Jan Scheffer, PD Dr. Hagen Maxeixner, D.E.S.A., E.D.I.C., Prof. Dr. med. Jörg Mühling, MBA

Erschienen in: Schmerzmedizin | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Zusammenfassung

Millionen Menschen leiden unter chronischen Rückenschmerzen. Allerdings sind der Therapie von chronischem nicht spezifischem Kreuzschmerz Grenzen gesetzt. Gerade die Wirkung einer medikamentösen Behandlung ist nicht selten unzureichend. Eine Supplementation mit Vitamin C kann sich lindernd auf den Schmerz auswirken.
Literatur
1.
2.
3.
4.
Nationale Versorgungsleitlinie Kreuzschmerz Langfassung. 1. Auflage, Version 5, November 2010, AWMF-Register: nvl/007
5.
Airaksinen O et al. COST B13 Working Group on Guidelines for Chronic Low Back Pain. Chapter 4. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J 2006;15 Suppl 2:S192–300PubMedPubMedCentralCrossRef
6.
Kuss K et al. Activating therapy modalities in older individuals with chronic non-specific low back pain: a systematic review. Physiotherapy 2015;101 (4)}:310–8PubMedCrossRef
7.
Illés ST. [Low back pain: when and what to do]. Orv Hetil 2015;156 (33)}:1315–20 Review HungarianPubMedCrossRef
8.
Kizhakkeveettil A et al. Integrative therapies for low back pain that include complementary and alternative medicine care: a systematic review. Glob Adv Health Med 2014;3 (5)}:49–64PubMedPubMedCentralCrossRef
9.
Böger A. [Multimodal pain therapy in chronic low back pain]. MMW Fortschr Med 2014;156 Spec no 2:73–6PubMedCrossRef
10.
Hsu E, Murphy S, Chang D, Cohen SP. Expert opinion on emerging drugs: chronic low back pain. Expert Opin Emerg Drugs 2015;20 (1)}:103–27PubMedCrossRef
11.
Veizi E, Hayek S. Interventional therapies for chronic low back pain. Neuromodulation 2014;17 Suppl 2:31–45PubMedCrossRef
12.
Webster LR, Markman J. Medical management of chronic low back pain: efficacy and outcomes. Neuromodulation 2014;17 Suppl 2:18–23PubMedCrossRef
13.
14.
15.
Slade SC et al. Barriers to primary care clinician adherence to clinical guidelines for the management of low back pain: protocol of a systematic review and meta-synthesis of qualitative studies. BMJ Open 2015;5 (4)}:e007265PubMedPubMedCentralCrossRef
16.
Steffens D et al. Prevention of Low Back Pain: A Systematic Review and Meta-analysis. JAMA Intern Med 2016;176 (2)}:199–208PubMedCrossRef
17.
Hart A et al. The Role of Vitamin C in Orthopedic Trauma and Bone Health. Am J Orthop (Belle Mead NJ) 2015;44 (7)}:306–11
18.
Jacob RA, Sotoudeh G. Vitamin C function and status in chronic disease. Nutr Clin Care 2002;5 (2)}:66–74PubMedCrossRef
19.
20.
Monsen ER. Dietary reference intakes for the antioxidant nutrients: vitamin C, vitamin E, selenium, and carotenoids. J Am Diet Assoc 2000;100 (6)}: 637–40PubMedCrossRef
21.
Padh H. Vitamin C: newer insights into its biochemical functions. Nutr Rev 1991;49 3)}: 65–70PubMedCrossRef
22.
Gershoff SN. Vitamin C (ascorbic acid): new roles, new requirements? Nutr Rev 1993; 51(11):313–26PubMedCrossRef
23.
Li Y, Schellhorn HE. New developments and novel therapeutic perspectives for vitamin C. J Nutr 2007;137 (10)}:2171–84PubMed
24.
Szent-Györgyi A. On the function of hexuronic acid in the respiration of the cabbage leaf. J Biol Chem 1931;90 1)}:385–93
25.
26.
Pauling L. Vitamin C and the Common Cold. Freeman, San Francisco; 1970
27.
28.
Chappell LC et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 1999;354 9181)}:810–16PubMedCrossRef
29.
Block G. Vitamin C and cancer prevention: the epidemiologic evidence. Am J Clin Nutr 1991;53 1 suppl)}:270S–282S.PubMed
30.
Creagan ET et al. Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med 1979;301 13)}:687–90PubMed
31.
Hemila H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev 2013;1: CD000980
32.
Poston L et al. Vitamins in Pre-eclampsia (VIP) Trial Consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 2006;367 (9517)}:1145–54PubMed
33.
Roberts JM et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Vitamins C and E to prevent complications of pregnancy associated hypertension. N Engl J Med 2010;362(14): 1282–91PubMedPubMedCentralCrossRef
34.
35.
Levine Met al. Criteria and recommendations for vitamin C intake. JAMA 1999;281 15)}:1415–23PubMedCrossRef
36.
Glatthaar BE et al. The role of ascorbic acid in carcinogenesis. Adv Exp Med Biol 1986; 206:357–77PubMed
37.
Carpenter KJ. The History of Scurvy and Vitamin C. Cambridge University Press New York; 1986
38.
39.
Leonard BE. Pain, Depression and Inflammation: Are Interconnected Causative Factors Involved? Mod Trends Pharmacopsychiatri 2015;30:22–35PubMedCrossRef
40.
Muley MM et al. Preclinical Assessment of Inflammatory Pain. CNS Neurosci Ther 2016;22 (2)}:88–101PubMedCrossRef
41.
Dionne CE et al. Serum vitamin C and spinal pain: a nationwide study. Pain 2016 Jul 18
42.
Finck H et al. Cross-sectional and prospective associations between dietary and plasma vitamin C, heel bone ultrasound, and fracture risk in men and women in the European Prospective Investigation into Cancer in Norfolk cohort. Am J Clin Nutr 2015;102 (6)}:1416–24PubMedCrossRef
43.
Kim YA et al. Favorable effect of dietary vitamin C on bone mineral density in postmenopausal women (KNHANES IV, 2009): discrepancies regarding skeletal sites, age, and vitamin D status. Osteoporos Int 2015;26 (9)}:2329–37PubMedCrossRef
44.
Mediati RD et al. Pathogenesis and clinical aspects of pain in patients with osteoporosis. Clin Cases Miner Bone Metab 2014;11 (3)}: 169–72PubMedPubMedCentral
45.
46.
Hall SL, Greendale GA. The relation of dietary vitamin C intake to bone mineral density: results from the PEPI study. Calcif Tissue Int 1998;63 3)}:183–89PubMedCrossRef
47.
Maggio D et al. Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. J Clin Endocrinol Metab 2003;88 (4)}:1523–27PubMedCrossRef
48.
Kaptoge S et al. Effects of dietary nutrients and food groups on bone loss from the proximal femur in men and women in the 7th and 8th decades of age. Osteoporosis Int 2003;14 (5)}:418–28CrossRef
49.
Pasco JA et al. Antioxidant vitamin supplements and markers of bone turnover in a community sample of nonsmoking women. J Womens Health 2006;15 (3)}:295–300CrossRef
50.
Leveille SG et al. Dietary vitamin C and bone mineral density in postmenopausal women in Washington state, USA. J Epidemiol Community Health 1997;51 5)}:479–85PubMedPubMedCentralCrossRef
51.
Simon JA, Hudes ES. Relation of ascorbic acid to bone mineral density and self-reported fractures among US adults. Am J Epidemiol 2001;154 (5)}: 427–33PubMedCrossRef
52.
Wolf RL et al. Lack of a relation between vitamin and mineral antioxidants and bone mineral density: results from the Women’s Health Initiative. Am J Clin Nutr 2005;82 (3)}: 581–8PubMed
53.
Schöffel D, Ringe J. Osteoporose und Schmerz. Bundesselbsthilfeverband für Osteoporose e.V. (BfO). 2013
54.
Bourne G. The effect of graded doses of vitamin C upon the regeneration of bone in guinea-pigs on a scorbutic diet. J Physiol 1942;101 3)}:327–36PubMedPubMedCentralCrossRef
55.
Bourne GH. The relative importance of periosteum and endosteum in bone healing and the relationship of vitamin C to their activities. Proc R Soc Med 1944;37 6)}:275–79PubMedPubMedCentral
56.
Sarisözen B, Durak K, Dinçer G, Bilgen OF. The effects of vitamins E and C on fracture healing in rats. J Int Med Res 2002;30 (3)}: 309–13PubMedCrossRef
57.
Yilmaz C et al. The contribution of vitamin C to healing of experimental fractures. Arch Orthop Trauma Surg 2001;121 (7)}:426–28PubMedCrossRef
58.
Kipp DE et al. Scurvy results in decreased collagen synthesis and bone density in the guinea pig animal model. Bone 1996;18 3)}: 281–8PubMedCrossRef
59.
Alcantara-Martos T et al. Effect of vitamin C on fracture healing in elderly osteogenic disorder Shionogi rats. J Bone Joint Surg Br 2007;89 (3)}:402–7PubMedCrossRef
60.
Mohan S et al. Spontaneous fractures in the mouse mutant sfx are caused by deletion of the gulonolactone oxidase gene, causing vitamin C deficiency. J Bone Miner Res 2005;20 (9)}:1597–1610PubMedCrossRef
61.
Xiao G et al. Ascorbic acid-dependent activation of the osteocalcin promoter in MC3T3-E1 preosteoblasts: requirement for collagen matrix synthesis and the presence of an intact OSE2 sequence. Mol Endocrinol 1997;11 8)}:1103–13PubMedCrossRef
62.
Aronow MA et al. Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells. J Cell Physiol 1990;143 2)}:213–21PubMedCrossRef
63.
Franceschi RT, Iyer BS. Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. J Bone Miner Res 1992;7 2)}:235–46PubMedCrossRef
64.
Leboy PS et al. Ascorbic acid induces alkaline phosphatase, type X collagen, and calcium deposition in cultured chick chondrocytes. J Biol Chem 1989;264 29)}:17281–6PubMed
65.
Sakamoto Y, Takano Y. Morphological influence of ascorbic acid deficiency on endochondral ossification in osteogenic disorder Shionogi rat. Anat Rec 2002;268 (2)}:93–104PubMedCrossRef
66.
Kim W et al. Ascorbic acid insufficiency induces the severe defect on bone formation via the down-regulation of osteocalcin production. Anat Cell Biol 2013;46 (4)}:254–61PubMedPubMedCentralCrossRef
67.
Melhus H et al. Smoking, antioxidant vitamins, and the risk of hip fracture. J Bone Miner Res 1999;14 1)}:129–35PubMedCrossRef
68.
Zhang J et al. Antioxidant intake and risk of osteoporotic hip fracture in Utah: an effect modified by smoking status. Am J Epidemiol 2006;163 (1)}:9–17PubMedCrossRef
69.
Sahni S et al. Protective effect of total carotenoid and lycopene intake on the risk of hip fracture: a 17-year follow-up from the Framingham Osteoporosis Study. J Bone Miner Res 2009;24 (6)}:1086–94PubMedPubMedCentralCrossRef
70.
Henrotin Y et al. Production of active oxygen species by isolated human chondrocytes. Br J Rheumatol 1993;32 7)}:562–7PubMedCrossRef
71.
McAlindon TE et al. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis? Arthritis Rheum 1996;39(4):648–56PubMedCrossRef
72.
Kaiki G et al. Osteoarthrosis induced by intra-articular hydrogen peroxide injection and running load. J Orthop Res 1990;8 5)}: 731–40PubMedCrossRef
73.
Regan EA et al. Joint fluid antioxidants are decreased in osteoarthritic joints compared to joints with macroscopically intact cartilage and subacute injury. Osteoarthritis Cartilage 2008;16 (4)}:515–21PubMedCrossRef
74.
Meacock SC et al. Experimental osteoarthritis in guinea-pigs. J Exp Pathol 1990;71 2)}: 279–93
75.
Kurz B et al. Dietary vitamins and selenium diminish the development of mechanically induced osteoarthritis and increase the expression of antioxidative enzymes in the knee joint of STR/1N mice. Osteoarthritis Cartilage 2002;10 (2)}:119–26PubMedCrossRef
76.
Kraus VB et al. Ascorbic acid increases the severity of spontaneous knee osteoarthritis in a guinea pig model. Arthritis Rheum 2004;50 (6)}:1822–31PubMedCrossRef
77.
Wang Y et al. Effect of antioxidants on knee cartilage and bone in healthy, middle-aged subjects: a cross-sectional study. Arthritis Res Ther 2007;9 (4)}:R66PubMedPubMedCentralCrossRef
78.
Peregoy J, Wilder FV. The effects of vitamin C supplementation on incident and progressive knee osteoarthritis: a longitudinal study. Public Health Nutr 2011;14 (4)}:709–15PubMedCrossRef
79.
Hill J, Bird HA. Failure of selenium-ace to improve osteoarthritis. Br J Rheumatol 1990;29 3)}:211–13PubMedCrossRef
80.
Chaganti RK et al. Multicenter Osteoarthritis Study Group (MOST). High plasma levels of vitamin C and E are associated with incident radiographic knee osteoarthritis. Osteoarthritis Cartilage 2014;22 (2)}:190–6
81.
82.
Zollinger PE et al. Effect of vitamin C on frequency of reflex sympathetic dystrophy in wrist fractures: a randomized trial. Lancet 1999;354 9195)}:2025–8PubMedCrossRef
83.
Zollinger PE et al. Can vitamin C prevent complex regional pain syndrome in patients with wrist fractures? A randomized, controlled, multicenter dose-response study. J Bone Joint Surg Am 2007;89 (7)}:1424–31PubMed
84.
Cazeneuve JF et al. Vitamin C and prevention of reflex sympathetic dystrophy following surgical management of distal radius fractures [in French]. Acta Orthop Belg 2002;68 (5)}:481–4PubMed
85.
Besse JL et al. Effect of vitamin C on prevention of complex regional pain syndrome type I in foot and ankle surgery. Foot Ankle Surg 2009;15 (4)}:179–82PubMedCrossRef
86.
Goris RJ et al. Are toxic oxygen radicals involved in the pathogenesis of reflex sympathetic dystrophy? Free Radic Res Commun 1987;3(1-5):13–18PubMedCrossRef
87.
Matsuda T et al. High-dose vitamin C therapy for extensive deep dermal burns. Burns 1992;18 2)}:127–31PubMedCrossRef
88.
Matsuda T et al. Effects of high-dose vitamin C administration on postburn microvascular fluid and protein flux. J Burn Care Rehabil 1992;13 5)}:560–66PubMedCrossRef
89.
Veldman PH et al. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet 1993;342 8878)}:1012–16PubMedCrossRef
90.
Zollinger PE. The administration of vitamin C in prevention of CRPS-I after distal radial fractures and hand surgery—a review of two RCTs and one observational prospective study. Open Conference Proc J 2011;2:1–4CrossRef
91.
Rogers BA et al. Can vitamin C prevent complex regional pain syndrome in patients with wrist fractures? J Bone Joint Surg Am 2008;90(2):447–8PubMed
92.
Amadio PC. Vitamin C reduced the incidence of reflex sympathetic dystrophy after wrist fracture. J Bone Joint Surg Am 2000;82 (6):873PubMedCrossRef
93.
Frolke JP. Can vitamin C prevent complex regional pain syndrome in patients with wrist fractures? J Bone Joint Surg Am 2007; 89(11):2550–1PubMedCrossRef
94.
Zollinger, P.E.,  et al. 2010Clinical results of 40 consecutive basal thumb prostheses and no CRPS type I after vitamin C prophylaxisOpen Orthop J4626PubMedPubMedCentral
95.
Shibuya N et al. Efficacy and safety of high-dose vitamin C on complex regional pain syndrome in extremity trauma and surgery-systematic review and meta-analysis. J Foot Ankle Surg 2013;52 (1)}:62–6PubMedCrossRef
96.
Li R et al. Vitamin C enhances the analgesic effect of gabapentin on rats with neuropathic pain. Life Sci 2016;157:25–31PubMedCrossRef
97.
98.
Park JM et al. Antiallodynic effects of vitamin C and vitamin E in chronic post-ischemia pain rat model. Korean J Anesthesiol 2013;65 (5)}:442–8PubMedPubMedCentralCrossRef
99.
Lu R et al. Additive antinociceptive effects of a combination of vitamin C and vitamin E after peripheral nerve injury. PLoS One 2011;6 (12)}:e29240PubMedPubMedCentralCrossRef
100.
Rosa KA et al. Evidence for the involvement of glutamatergic system in the antinociceptive effect of ascorbic acid. Neurosci Lett 2005;381 (1-2)}:185–8PubMedCrossRef
101.
Gan R et al. Vitamin C deficiency in a university teaching hospital. J Am Coll Nutr 2008;27 (3)}:428–33PubMedCrossRef
102.
US Department of Agriculture, Agricultural Research Service. USDA National Nutrient Database for Standard Reference. Release 26. http://​www.​ars.​usda.​gov/​Services/​docs.​htm?​docid=​24936. Published August 2013. Revised November 2013. Accessed May 14, 2015. National Institutes of Health, Office of Dietary Supplements. Vitamin C: fact sheet for health professionals.
103.
104.
Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press; 2000.
105.
PDQ Cancer Complementary and Alternative Medicine Editorial Board. High-Dose Vitamin C (PDQ®): Health Professional Version. 2015 Jun 29. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002
106.
Berger MM, Oudemans-van Straaten HM. Vitamin C supplementation in the critically ill patient. Curr Opin Clin Nutr Metab Care 2015;18 (2)}:193–201PubMedCrossRef
107.
108.
Wilson MK et al. Review of high-dose intravenous vitamin C as an anticancer agent. Asia Pac J Clin Oncol 2014;10 (1)}:22–37PubMedCrossRef
109.
110.
111.
112.
Fain O et al. Hypovitaminosis C in hospitalized patients. Eur J Intern Med. 2003;14 (7)}:419–25PubMedCrossRef
113.
Blee TH et al. Hemorrhage associated with vitamin C deficiency in surgical patients. Surgery 2002;131 (4)}:408–12PubMedCrossRef
114.
Schleicher RL et al. Serum vitamin C and the prevalence of vitamin C deficiency in the United States: 2003-2004 National Health and Nutrition Examination Survey (NHANES). Am J Clin Nutr 2009;90 (5)}:1252–63PubMedCrossRef
Metadaten
Titel
Supplementation
Vitamin C beim chronischen nicht spezifischen Kreuzschmerz
verfasst von
Olaf Buchbinder
Dr. Geert-Jan van Geffen
Prof. Dr. Gert Jan Scheffer
PD Dr. Hagen Maxeixner, D.E.S.A., E.D.I.C.
Prof. Dr. med. Jörg Mühling, MBA
Publikationsdatum
30.01.2017
Verlag
Springer Medizin
Erschienen in
Schmerzmedizin / Ausgabe 1/2017
Print ISSN: 2194-2536
Elektronische ISSN: 2364-1010
DOI
https://doi.org/10.1007/s00940-017-0495-6

Weitere Artikel der Ausgabe 1/2017

Schmerzmedizin 1/2017 Zur Ausgabe

DGS_Deutsche Gesellschaft für Schmerzmedizin e.V.

FDA ruft höchste Warnstufe aus

Berufsverband der Palliativmediziner

Opioide weitergeben, ohne zu dealen

Kurz gemeldet

Zur selbständigen Tätigkeit von Honorarärzten

DGS_Deutsche Gesellschaft für Schmerzmedizin e.V.

Therapie häufig ohne ausreichendes Konzept

Editorial

Gesetzentwürfe mit erheblicher Sprengkraft

Praxis konkret

Patienten wollen die Online-Verordnung

Neu im Fachgebiet AINS

11.04.2024 | Rückenschmerzen | Nachrichten

Diclofenac-Gel versus Ibuprofen bei akuten Rückenschmerzen

10.04.2024 | Postoperative Schmerztherapie | Nachrichten

Chronische Schmerzen nach Op. oft mit neuropathischer Komponente

08.04.2024 | Andrologie | Nachrichten

Wie toxische Männlichkeit der Gesundheit von Männern schadet

04.04.2024 | DGP 2024 | Kongressbericht | Nachrichten

Neue NIV-Leitlinie mit Anleitung zur Beatmungseinstellung vorgestellt
weitere anzeigen

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren